Staccato reperfusion prevents reperfusion injury in patients undergoing coronary angioplasty: A 1-year follow-up pilot study

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 497-502

  Iliodromitis, Efstathios K ^a   Paraskevaidis, Ioannis A ^a   Fountoulaki, Katerina ^a   Farmakis, Dimitrios ^a   Andreadou, Ioanna ^b   Antoniadis, Aias ^a   Ikonomidis, Ignatios ^a   Leftheriotis, Dionyssios ^a   Kremastinos, Dimitrios T ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Angioplasty; Humans; Ischemia; Postconditioning; Reperfusion

Indexed keywords

3 NITROTYROSINE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MALONALDEHYDE; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BALLOON DILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; LIPID PEROXIDATION; MALE; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; STACCATO REPERFUSION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; PILOT PROJECTS; RECOVERY OF FUNCTION; RECURRENCE; STENTS; TIME FACTORS; TREATMENT OUTCOME; TYROSINE; VENTRICULAR FUNCTION, LEFT;

EID: 67349178144     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.09.037     Document Type: Article

References (36)

1. Reimer K.A., Jennings R.B., and Tataum A.H. Pathobiology of acute myocardial ischemia: metabolic, functional and ultra structural studies. Am J Cardiol 52 (1983) 72A-81A
2. Van de Werf. Thrombolysis for acute myocardial infarction. Haemostasis 24 (1994) 65-68
3. Nallamothu B.K., Bradley E.H., and Krumholz H.M. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 357 (2007) 1631-1638
4. Crisostomo P.R., Wairiuko G.M., Wang M., Tsai B.M., Morrell E.D., and Meldrum D.R. Preconditioning versus postconditioning: mechanisms and therapeutics potentials. J Am Coll Surg 202 (2006) 797-812
5. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 357 (2007) 1121-1135
6. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
7. Zhao Z.Q., Corvera J.S., Halkos M.E., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol 285 (2003) H579-588
8. Laskey W.K. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 65 (2005) 361-367
9. Ma X., Zhang X., Li C., and Luo M. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interv Cardiol 19 (2006) 367-375
10. Loukogeorgakis S.P., Panagiotidou A.T., Yellon D.M., Danfield J.E., and Mac Allister R.J. Postconditioning protects against endothelial ischemia-reperfusion injury in the human forearm. Circulation 113 (2006) 1015-1019
11. Staat P., Rioufol G., Piot C., et al. Postconditioning the human heart. Circulation 112 (2005) 2143-2148
12. Thibault H., Piot C., Staat P., et al. Long-term benefit of postconditioning. Circulation 117 (2008) 1037-1044
13. Andreadou I., Iliodromitis E.K., Tsovolas K., et al. Acute administration of vitamin E triggers preconditioning via KATP channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med 41 (2006) 1092-1099
14. Piper H.M., Garcia-Dorado D., and Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 38 (1998) 291-300
15. Andreotti F., Pasceri V., Hackett D.R., Davies G.J., Haider A.W., and Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 334 (1996) 7-12
16. Jenkins D.P., Pugsley W.B., Alkhulaifi A.M., Kemp M., Hooper J., and Yellon D.M. Ischemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77 (1997) 314-318
17. Gheeraert P.J., Henriques J.P., De Buyzere M.L., De Pauw M., Taeymans Y., and Zijlstra F. Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery. J Am Coll Cardiol 38 (2001) 1369-1376
18. Iliodromitis E.K., Zoga A., Vrettou A., et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 188 (2006) 356-362
19. Kin H., Zhao Z.-Q., Sun H.-Y., et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62 (2004) 74-85
20. Yang X.M., Philipp S., Downey J.M., and Cohen M.V. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 100 (2005) 57-63
21. Hearse D.J., Humphrey S.M., and Chain E.B. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 5 (1973) 395-407
22. Lemasters J.J., Bond J.M., Chacon E., et al. The pH paradox in ischemia-reperfusion injury to cardiac myocytes. EXS 76 (1996) 99-114
23. Parissis J.T., Andreadou I., Markantonis S.L., et al. Effects of levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure. Atherosclerosis 195 (2007) 210-215
24. Halkos M.E., Kerendi F., Corvera J.S., et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 78 (2004) 961-969
25. Wang H., Zhang H., Guo W., et al. Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation. Apoptosis 11 (2006) 1453-1460
26. Zhao Z.Q., Corvera J.S., Halkos M.E., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579-588
27. Liu Y., Yang X.M., Iliodromitis E.K., et al. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res Cardiol 103 (2008) 54-59
28. Dost T., Cohen M.V., and Downey J.M. Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning. Basic Res Cardiol 103 (2008) 378-384
29. Zweire J.L., Wang P., and Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 270 (1995) 304-307
30. Kloner RA, Bolli R, Marban E, Reinlib L, Branwald E and participants. Medical and cellular implications of stunning, hibernation and preconditioning. An NHLBI Workshop. Circulation 1998;97:1848-67.
31. Paraskevaidis I.A., Iliodromitis E.K., Vlahakos D., et al. Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance. Eur Heart J 26 (2005) 263-270
32. Hausenloy D.J., and Yellon D.M. Preconditioning and postconditioning: new strategies for cardioprotection. Diabetes Obes Metab 10 (2008) 451-459
33. Kyriakides Z.S., Psychari S., Iliodromitis E.K., Kolettis T.M., Sbarouni E., and Kremastinos D.T. Hyperlipidemia prevents the expected reduction of myocardial ischemia on repeated balloon inflations during angioplasty. Chest 121 (2002) 1211-1215
34. Matsuo H., Watanabe S., Segawa T., et al. Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensitive K+ channel opener nicorandil. Eur Heart J 24 (2003) 1296-1303
35. Leesar M.A., Stoddard M.F., Xuan Y.T., Tang X.L., and Bolli R. Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans. J Am Coll Cardiol 42 (2003) 437-445
36. Matsubara T., Minatoguchi S., Matsuo H., et al. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol 35 (2000) 345-351